no do not think its the posts - anyone doing DD can see that:
1) ACR was doing very well with the Eli arrangement;
2) RT left and things started to "unwind";
3) ELI arrangement finished - panic set in;
4) went on a generic path to save time and funds on way to the market - but hasn't worked out;
5) payment of bonuses based on non-transparent KPI's (with the SP having relatively minor if any consideration as being a factor);
6) Harris debacle;
7) the biggie IMO - the substantial cash outflows - being so totally cashed up not too long ago to where it is at now - with little to show for that expenditure - did they review costs?;
8) other biggie - from last financial reports - there will be a need for further CR by years end. Given SP levels that could well entail a HUGE dilution - lets face it they won't go for a few million CR it will be substantial so they don't keep going to market for further CR's should the sales be lacking. So a rather large CR = HUGE dilution (as if the dilution not bad enough over recent CR's).
market can see how the company is being run and obviously making decisions based on that and expectations given the ANN's/finncial reports that have been released - so IMO its not these posts that are creating the issue its the company itself maybe due to the above.
only need to see the SP from a few years back to where it is now - surely one would question why that is the case - and by digging deeper they will obviously make their own conclusions and for SP to be where it ios - market can't be too impressed with the way things are (IMO).
happy to be corrected in the event i have missed something.
- Forums
- ASX - By Stock
- ACR
- Ann: Appendix 4D, Half Year Accounts as at 31 December 2021
Ann: Appendix 4D, Half Year Accounts as at 31 December 2021, page-31
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACR (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.79M |
Open | High | Low | Value | Volume |
4.4¢ | 4.4¢ | 4.4¢ | $820 | 18.64K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 98384 | 4.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.6¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 98384 | 0.044 |
2 | 547000 | 0.043 |
2 | 94414 | 0.041 |
3 | 322500 | 0.040 |
1 | 120000 | 0.039 |
Price($) | Vol. | No. |
---|---|---|
0.046 | 10000 | 1 |
0.047 | 24318 | 1 |
0.048 | 144500 | 4 |
0.049 | 120000 | 1 |
0.052 | 103000 | 2 |
Last trade - 10.00am 18/11/2024 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online